Literature DB >> 16529523

Natural products in combinatorial chemistry: an andrographolide-based library.

Christian Mang1, Sven Jakupovic, Stefan Schunk, Horst-Dieter Ambrosi, Oliver Schwarz, Jasmin Jakupovic.   

Abstract

The generation of a natural-product-based library starting from andrographolide is described. Utilizing andrographolide itself in parallel solution-phase synthesis leads to a 360-membered library. The initial transformation of the starting material via ozonolysis is followed by the conversion into a suitable template by introduction of a thiazole moiety. Subsequent decoration at two points of diversity yields the desired natural product derivatives. The selection of actually synthesized compounds is based on a virtually generated library and the assessment of its members with respect to physicochemical parameters, thus ensuring pharmacological relevance of the compounds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16529523     DOI: 10.1021/cc050143n

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  4 in total

Review 1.  Alkynoates as Versatile and Powerful Chemical Tools for the Rapid Assembly of Diverse Heterocycles under Transition-Metal Catalysis: Recent Developments and Challenges.

Authors:  Imtiaz Khan; Aliya Ibrar; Sumera Zaib
Journal:  Top Curr Chem (Cham)       Date:  2021-01-05

2.  Synthesis of a natural product-inspired eight-membered ring lactam library via ring-closing metathesis.

Authors:  Neil Brown; Baohan Xie; Nataliya Markina; David Vandervelde; Jean-Pierre H Perchellet; Elisabeth M Perchellet; Kyle R Crow; Keith R Buszek
Journal:  Bioorg Med Chem Lett       Date:  2008-07-24       Impact factor: 2.823

3.  Remodelling of the natural product fumagillol employing a reaction discovery approach.

Authors:  Bradley R Balthaser; Meghan C Maloney; Aaron B Beeler; John A Porco; John K Snyder
Journal:  Nat Chem       Date:  2011-12       Impact factor: 24.427

4.  Andrographolide: a new plant-derived antineoplastic entity on horizon.

Authors:  Astha Varma; Harish Padh; Neeta Shrivastava
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-10       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.